MedTrace Logo

CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia

NCT04700930 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-06-23

No results posted yet for this study

Summary

Interventional study using Cannabidiol containing cigarettes as replacement of usual cigarettes

Reduction of enforcement measures, improved acute treatment, harm reduction, and improvement of psychotic symptoms

Conditions

  • Schizophrenia and Other Psychotic Disorders
  • Harm Reduction

Interventions

OTHER

CBD-Cigarettes

CBD-Cigarettes instead of normal Cigarettes: The participants in this arm receive CBD-Cigarettes which are then inhaled/smoked instead of their normal tobacco cigarettes

Sponsors & Collaborators

  • Psychiatric Hospital of the University of Basel

    lead OTHER

Principal Investigators

  • Undine Lang, Prof. Dr. · Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-04
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04700930 on ClinicalTrials.gov